Non-Viral Technologies for in vivo Delivery of Genome Editors (R43/R44 Clinical Trial Not Allowed)
(PAR-20-098)
National Center for Advancing Translational Sciences
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of General Medical Sciences
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s):
Standard dates apply
The first standard due date for this FOA is April 5, 2020
Laboratory Flexible Funding Model (LFFM) (U19) Clinical Trials Not Allowed
(PAR-20-105)
Food and Drug Administration
Application Receipt Date(s):
May 6, 2020 by 11:59 PM Eastern Time
April 6, 2021 by 11:59 PM Eastern Time.
April 6, 2022 by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
Centers for AIDS Research (P30 Clinical Trial Not Allowed)
(PAR-20-106)
National Institute of Allergy and Infectious Diseases
John E. Fogarty International Center
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Aging Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
Application Receipt Date(s):
Only accepting applications for the AIDS Application Due Date(s) listed below.
Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)
(PAR-20-107)
National Institute of Allergy and Infectious Diseases
John E. Fogarty International Center
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Aging Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
Application Receipt Date(s):
Only accepting applications for the AIDS Application Due Date(s) listed below.
Non-Viral Technologies for in vivo Delivery of Genome Editors (R41/R42 Clinical Trial Not Allowed)
(PAR-20-109)
National Center for Advancing Translational Sciences
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of General Medical Sciences
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s):
Standard dates apply
The first standard due date for this FOA is April 5, 2020
Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed)
(RFA-OD-20-008)
Office of Disease Prevention
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Application Receipt Date(s):
July 8, 2020, February 08, 2021, October 08, 2021, July 8, 2022)
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed)
(RFA-OD-20-009)
Office of Disease Prevention
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Application Receipt Date(s):
July 8, 2020, February 08, 2021, October 08, 2021, July 8, 2022
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required)
(RFA-OD-20-010)
Office of Disease Prevention
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Drug Abuse
Application Receipt Date(s):
July 8, 2020, February 08, 2021, October 08, 2021, July 8, 2022
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required)
(RFA-OD-20-011)
Office of Disease Prevention
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Drug Abuse
Application Receipt Date(s):
July 8, 2020, February 08, 2021, October 08, 2021, July 8, 2022
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.